Summary & Overview
HCPCS G8854: Documentation of Non-Reportable Adherence to Evidence-Based Therapy
HCPCS Level II code G8854 captures documentation of reasons why objective reporting of adherence to evidence-based therapy is not possible. The code is used when clinical circumstances, patient choice, access barriers, or payer coverage limitations prevent routine adherence measurement. Nationally, accurate use of G8854 affects quality reporting, performance measure denominators, and administrative records for patients who cannot be assessed under standard adherence metrics. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication explains what G8854 represents, the clinical contexts in which it is applied, and how major payers approach its recognition. Readers will find a concise explanation of the code’s purpose, the service type and typical sites of service, and what to expect in payer coverage language. The piece also outlines common reporting scenarios and the implications for quality measurement and administrative documentation. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G8854 documents the reason(s) for not objectively reporting adherence to evidence-based therapy. Typical scenarios captured by this code include patients with a terminal or advanced disease and an expected lifespan of less than six months, patients who decline therapy, patients who do not return for at least annual follow-up, patients unable to access or afford therapy, or when a patient’s insurance will not cover therapy. The service type is documentation of non-reportable adherence to evidence-based therapy. The typical site of service is outpatient clinical settings where therapy adherence and follow-up would normally be assessed, including specialty clinics, primary care offices, and ambulatory care centers.
Clinical & Coding Specifications
Clinical Context
A patient with a chronic condition (for example, advanced congestive heart failure, metastatic cancer, or severe chronic obstructive pulmonary disease) attends a specialty or primary care visit where the clinician documents why objective adherence to evidence-based therapy is not reported. Typical scenario: a 72‑year‑old with metastatic lung cancer and estimated life expectancy under six months declines systemic therapy and elects hospice care. During a medication reconciliation and treatment planning visit in an outpatient oncology clinic or primary care office, the clinician documents discussion of evidence‑based therapy, patient preferences, barriers (cost, access), inability to return for at least annual follow‑up, and/or terminal prognosis. The documentation specifies one or more valid reasons for not objectively reporting adherence (e.g., patient declines therapy, insurance will not cover, limited life expectancy, inability to access/afford therapy, or loss to follow up).
Typical workflow: the clinician assesses diagnosis and treatment options, reviews prior adherence data if available, documents the reason(s) for not objectively reporting adherence to guideline therapy in the medical record, and includes relevant informed refusal or advance care planning notes. This documentation is recorded in the outpatient electronic health record during visits in settings such as outpatient oncology clinics, palliative care clinics, primary care offices, hospice admission encounters, or skilled nursing facility care planning meetings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |